We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bivictrix Therapeutics Plc | LSE:BVX | London | Ordinary Share | GB00BNXH3K91 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.50 | 11.00 | 12.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 11.50 | 10.90 | 11.50 | 0.00 | 08:00:14 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 0 | -2.5M | -0.0303 | -3.80 | 9.49M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 17/4/2024 | 14:23 | ALNC |  Bivictrix granted FDA orphan drug status for rare cancer treatment |
| 17/4/2024 | 07:00 | UK RNS | BiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT Meeting |
| 28/3/2024 | 07:00 | UK RNS | BiVictriX Therapeutics PLC Grant of Options – PDMR/Director Dealings |
| 04/1/2024 | 12:30 | UKREG | BiVictriX Therapeutics PLC Holding(s) in Company |
| 04/1/2024 | 12:30 | UKREG | BiVictriX Therapeutics PLC Holding(s) in Company |
| 04/1/2024 | 07:00 | UKREG | BiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable Discussion |
| 05/12/2023 | 11:08 | UKREG | BiVictriX Therapeutics PLC Board Change |
| 30/11/2023 | 12:08 | ALNC | IN BRIEF: Bivictrix selects final sequences for lead tumour programme |
| 30/11/2023 | 07:00 | UKREG | BiVictriX Therapeutics PLC Pipeline update on BVX002 |
| 22/11/2023 | 17:14 | UKREG | BiVictriX Therapeutics PLC Holding(s) in Company |
1 Year Bivictrix Therapeutics Chart |
Intraday Bivictrix Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
